Citadel Advisors’s Forbion European Acquisition Corp. Class A Ordinary Shares FRBN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-600,059
Closed -$6.44M 15440
2023
Q2
$6.44M Sell
600,059
-474,941
-44% -$5.03M ﹤0.01% 3270
2023
Q1
$11.3M Sell
1,075,000
-1
-0% -$10 ﹤0.01% 2638
2022
Q4
$11.1M Hold
1,075,001
﹤0.01% 2682
2022
Q3
$10.9M Buy
1,075,001
+1
+0% +$10 ﹤0.01% 2639
2022
Q2
$10.8M Sell
1,075,000
-1
-0% -$10 ﹤0.01% 2590
2022
Q1
$10.7M Buy
+1,075,001
New +$10.7M ﹤0.01% 2843

Other funds holding FRBN

Citadel Advisors's FRBN Position: Q3 2023 in Review

Citadel Advisors sold out of Forbion European Acquisition Corp. Class A Ordinary Shares (FRBN) in Q3 2023, closing a stake of 600,059 shares — an estimated $6.44M sold.

Citadel Advisors first reported a position in FRBN in Q1 2022 and held it in 6 quarters. The position peaked at $11.3M in Q1 2023. 33 funds tracked by Wall St. Rank hold FRBN as of Q3 2023.

  • Citadel Advisors reported no remaining Forbion European Acquisition Corp. Class A Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 600,059 Forbion European Acquisition Corp. Class A Ordinary Shares shares in Q3 2023, an estimated $6.44M.
  • Citadel Advisors first reported a position in Forbion European Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 6 quarters.
  • Citadel Advisors's Forbion European Acquisition Corp. Class A Ordinary Shares position peaked at $11.3M in Q1 2023.
  • 33 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Class A Ordinary Shares as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.